MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: The IGF-1R inhibitor BMS-754807, PI3K/mTOR inhibitor PF-04691502 and mTOR inhibitor AZD8055 were the most effective in CP CML patient samples.